The Grand Alliances - A new breed of players, with the ability to turn science into real-world solutions, is on the march. - BioPharm International

ADVERTISEMENT

The Grand Alliances
A new breed of players, with the ability to turn science into real-world solutions, is on the march.


BioPharm International


An example of how this translates into business benefit is Voxar, the Edinburgh-based company founded in 1995 by Andrew Bissell to develop three-dimensional medical visualization software solutions for the clinical market. Voxar's success in forging strategic partnerships with many of the world's leading original equipment manufacturers played a key part in the eventual acquisition of the company by the Belgian company Barco ( http://www.barco.com/) in September 2004. This move has led to major investment in the integrated business and significant growth in sales over the last two years.

Their agility, relatively rapid time to market, and reliance on proven technologies make convergence companies an attractive proposition to partners and investors alike. So, with Scotland's crop of homegrown talent knocking loudly on international doors, what is good for these companies is also good for our global standing and the advancement of medicine across the world.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

New Tax Rules May Deter Future Pharma M&A
October 1, 2014
NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
Author Guidelines
Source: BioPharm International,
Click here